180 related articles for article (PubMed ID: 18987546)
1. Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome.
Sparr JA; Bandipalliam P; Redston MS; Syngal S
Am J Surg Pathol; 2009 Feb; 33(2):309-12. PubMed ID: 18987546
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome.
Flanagan MR; Jayaraj A; Xiong W; Yeh MM; Raskind WH; Pillarisetty VG
World J Gastroenterol; 2015 Mar; 21(9):2820-5. PubMed ID: 25759555
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic mucinous noncystic (colloid) carcinomas and intraductal papillary mucinous carcinomas are usually microsatellite stable.
Lüttges J; Beyser K; Pust S; Paulus A; Rüschoff J; Klöppel G
Mod Pathol; 2003 Jun; 16(6):537-42. PubMed ID: 12808058
[TBL] [Abstract][Full Text] [Related]
4. Pseudomyxoma peritonei of a mature ovarian teratoma caused by mismatch repair deficiency in a patient with Lynch syndrome: a case report.
Gohda Y; Noguchi R; Horie T; Igari T; Nakamura H; Ohta Y; Yamaguchi K; Ikenoue T; Hatakeyama S; Yusa N; Furukawa Y; Yano H
BMC Med Genet; 2016 Dec; 17(1):94. PubMed ID: 27938333
[TBL] [Abstract][Full Text] [Related]
5. GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.
Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
Virchows Arch; 2015 Jun; 466(6):665-74. PubMed ID: 25796395
[TBL] [Abstract][Full Text] [Related]
6. Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene.
Banville N; Geraghty R; Fox E; Leahy DT; Green A; Keegan D; Geoghegan J; O'Donoghue D; Hyland J; Sheahan K
Hum Pathol; 2006 Nov; 37(11):1498-502. PubMed ID: 16996571
[TBL] [Abstract][Full Text] [Related]
7. Tracking the Clonal Evolution of Adenosquamous Carcinoma, a Rare Variant of Intraductal Papillary Mucinous Neoplasm of the Pancreas.
Matsuzaka S; Karasaki H; Ono Y; Ogata M; Oikawa K; Tamakawa S; Chiba S; Muraki M; Yokochi T; Funakoshi H; Kono T; Nagashima K; Mizukami Y
Pancreas; 2016 Jul; 45(6):915-8. PubMed ID: 27295533
[TBL] [Abstract][Full Text] [Related]
8. [Pancreatic tumor: progress in diagnosis and treatment. Topics: II. Intraductal papillary mucinous neoplasm of the pancreas (IPMN)/mucinous cystic neoplasm (MCN); 2. Pathology and pathobiology].
Furukawa T; Kuboki Y; Hatori T; Yamamoto M; Shibata N; Shiratori K
Nihon Naika Gakkai Zasshi; 2012 Jan; 101(1):57-63. PubMed ID: 22413462
[No Abstract] [Full Text] [Related]
9. Clinical role of Notch signaling pathway in intraductal papillary mucinous neoplasm of the pancreas.
Ikemoto T; Sugimoto K; Shimada M; Utsunomiya T; Morine Y; Imura S; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Yamada S
J Gastroenterol Hepatol; 2015 Jan; 30(1):217-22. PubMed ID: 25041344
[TBL] [Abstract][Full Text] [Related]
10. Synchronous breast cancers with different morphologic and molecular phenotypes occurring in Lynch syndrome: what does the heterogeneity imply?
D'Arcy C; Wen YH; Stadler ZK; Brogi E; Shia J
Am J Surg Pathol; 2011 Nov; 35(11):1743-8. PubMed ID: 21997695
[TBL] [Abstract][Full Text] [Related]
11. Lessons from McCune-Albright syndrome-associated intraductal papillary mucinous neoplasms: : GNAS-activating mutations in pancreatic carcinogenesis.
Parvanescu A; Cros J; Ronot M; Hentic O; Grybek V; Couvelard A; Levy P; Chanson P; Ruszniewski P; Sauvanet A; Gaujoux S
JAMA Surg; 2014 Aug; 149(8):858-62. PubMed ID: 24898823
[TBL] [Abstract][Full Text] [Related]
12. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
[TBL] [Abstract][Full Text] [Related]
13. Invasive ductal adenocarcinoma of the remnant pancreatic body 9 years after resection of an intraductal papillary-mucinous carcinoma of the pancreatic head: a case report and comparison of DNA sequence in K-ras gene mutation.
Komori T; Ishikawa O; Ohigashi H; Yamada T; Sasaki Y; Imaoka S; Nakaizumi A; Uehara H; Tanaka S; Mano Y; Kasugai T
Jpn J Clin Oncol; 2002 Apr; 32(4):146-51. PubMed ID: 12072425
[TBL] [Abstract][Full Text] [Related]
14. K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas.
Schoedel KE; Finkelstein SD; Ohori NP
Diagn Cytopathol; 2006 Sep; 34(9):605-8. PubMed ID: 16900481
[TBL] [Abstract][Full Text] [Related]
15. Telomere shortening and telomerase expression during multistage carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas.
Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Fukuda E; Shimamoto F; Sueda T; Hiyama E
J Gastrointest Surg; 2008 Jan; 12(1):17-28; discussion 28-9. PubMed ID: 17960465
[TBL] [Abstract][Full Text] [Related]
16. Hereditary intraductal papillary mucinous neoplasm of the pancreas.
Denost Q; Chafai N; Arrive L; Mourra N; Paye F
Clin Res Hepatol Gastroenterol; 2012 Apr; 36(2):e23-5. PubMed ID: 22225963
[TBL] [Abstract][Full Text] [Related]
17. Intraductal papillary mucinous neoplasm of the pancreas and IgG4-related disease: a coincidental association.
Tabata T; Kamisawa T; Hara S; Kuruma S; Chiba K; Kuwata G; Fujiwara T; Egashira H; Koizumi S; Endo Y; Koizumi K; Fujiwara J; Arakawa T; Momma K; Horiguchi S; Hishima T; Kurata M; Honda G; Kloppel G
Pancreatology; 2013; 13(4):379-83. PubMed ID: 23890136
[TBL] [Abstract][Full Text] [Related]
18. Patients with pancreatic intraductal papillary mucinous neoplasms are at high risk of colorectal cancer development.
Eguchi H; Ishikawa O; Ohigashi H; Tomimaru Y; Sasaki Y; Yamada T; Tsukuma H; Nakaizumi A; Imaoka S
Surgery; 2006 Jun; 139(6):749-54. PubMed ID: 16782429
[TBL] [Abstract][Full Text] [Related]
19. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas.
Wada K
J Hepatobiliary Pancreat Surg; 2002; 9(1):76-85. PubMed ID: 12021900
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.
Tanaka T; Kuroki T; Adachi T; Ono S; Hirabaru M; Soyama A; Kitasato A; Takatsuki M; Hayashi T; Eguchi S
Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]